Brief: Alimera Sciences And Tanner Pharma Group Initiate Global Named Patient Program For Iluvien
09/08/2021 14:23
Aug 9 (Reuters) - Alimera Sciences Inc ALIM.O :
* ALIMERA SCIENCES AND TANNER PHARMA GROUP INITIATE GLOBAL
NAMED
PATIENT PROGRAM FOR ILUVIEN®
* ALIMERA SCIENCES - AGREEMENT NAMES TANNER AS EXCLUSIVE
PROVIDER
OF ILUVIEN IN SPECIFIC COUNTRIES OUTSIDE OF U.S. ON A
NAMED-PATIENT BASIS
Source text for Eikon: ID:nGNX7Qtrpm
Further company coverage: ALIM.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Alimera Sciences
See all newsBrief: ANI Pharmaceuticals And Alimera Sciences Announce Closing Date Of Merger
Brief: Ani Pharmaceuticals Provides Update On Closing Of Acquisition Of Alimera Sciences
U.S. STOCKS ON THE MOVE-JPMorgan, automakers, energy firms
U.S. STOCKS ON THE MOVE-Arrowhead Pharma, Boeing, Centessa Pharma
Brief: Alimera Sciences Files Lawsuit To Compel ANI To Close Merger